GDPR for health data and the establishment of a compliant real-world evidence pipeline in Germany

You want to build a GDPR-compliant Real-World Evidence pipeline for health data in Germany. The data landscape in healthcare presents major challenges.

• Over 13% of gross domestic product flows into the German healthcare system.
• Numerous data holders create a complex structure.
• Fragmented data and non-transparent access make the work more difficult.

You need flexible, nationwide data-protection solutions. Anonymization and pseudonymization protect you and build trust when handling sensitive information.

Key insights

• Health data is particularly worthy of protection. You must define it precisely and observe the requirements of the GDPR.
• Real-World Evidence (RWE) complements clinical trials. It offers valuable insights from real-world care.
• Consent to process health data must be voluntary and unambiguous. Alternatives to consent are possible under certain conditions.
• Anonymization and pseudonymization are important methods to protect health data. They minimize risks and enable data analysis.
• Organizational and technical measures are crucial. You must implement clear access rights and regular training.

GDPR for health data: basics

Health data

You work with health data that is particularly worthy of protection. The GDPR for health data requires a precise definition of this data. The following table shows which aspects are relevant under the law:

You can see that health data goes far beyond classic diagnoses. It also includes genetic information and all characteristics that uniquely identify a person.

Real-World Evidence

Real-World Evidence (RWE) is becoming increasingly important in the German healthcare system. You use RWE to derive insights from large-scale data sources and observational studies. The most important characteristics of RWE are:

• RWE complements traditional clinical trials and provides a broader data basis.
• You receive information from real-world care that enables greater generalizability.
• The German Medical Technology Association calls for RWE to play a greater role in the benefit assessment of MedTech methods.

With RWE you can pursue innovative approaches and analyze care practices more effectively.

GDPR basics

The GDPR for health data forms the foundation for handling sensitive information. You must observe key legal requirements:

• Article 9 GDPR generally prohibits the processing of health data unless specific legal bases apply.
• Article 6 GDPR governs the general conditions for processing personal data.
• Section 22 BDSG (Federal Data Protection Act) supplements the GDPR and contains specific provisions for health data.
• You generally need the data subject’s consent, in particular under Article 9(2)(a) GDPR.

You ensure that all processes are transparent and legally compliant. The GDPR for health data protects privacy and builds trust in your work.

Legal requirements

GDPR for health data: requirements

You face the challenge of implementing the GDPR for health data in a complex and dynamic environment. The Federal Government is working on a simplification of how data protection for health data is interpreted. The aim is a nationwide, uniform regulation to be achieved through a reform of data protection oversight. Responsibilities will be consolidated under the Federal Commissioner for Data Protection and Freedom of Information (BfDI). Consent solutions are to be replaced by opt-out solutions. These measures promote uniform interpretation and offer relief, especially for small and medium-sized enterprises.

The general and specific data-protection requirements for health data are diverse. You must demonstrate special grounds to justify processing personal data. Additional conditions apply to sensitive health data. The guidance from the data protection authorities explains the requirements for consent and sets out best practices.

• You take organizational precautions to ensure the protection of health data.
• You bind employees to data confidentiality.
• You create a record of all data processing activities.
• Appointing a data protection officer is an essential requirement.

Data security plays a decisive role in healthcare. The GDPR for health data specifies the required level of protection. The guidance provides examples of appropriate security measures and requirements for dealing with data breaches.

Tip: Structured documentation of all processes and measures makes it easier to comply with legal requirements and creates transparency for supervisory authorities.

Consent and alternatives

Consent to process health data is a central aspect of the GDPR for health data. You need a freely given, specific, informed and unambiguous statement of intent from the data subject. Consent must be explicit. You relate the data processing to specific, pre-defined purposes. Voluntariness is crucial, and the prohibition on tying (Kopplungsverbot) must be observed.

1. Consent must be voluntary.
2. It is informed.
3. It relates to a specific purpose and a specific processing activity.
4. It is unambiguous.
5. It includes a notice of the right to withdraw consent.
6. For health data, explicit consent is required.

Alternatives to consent give you additional room to maneuver. The GDPR for health data allows processing of sensitive data under certain conditions:

• You may process data for fulfilling and exercising rights under an employment relationship.
• Processing for purposes of preventive or occupational medicine is permissible.
• The establishment, exercise, or defense of legal claims is another legitimate ground.
• Scientific research purposes provide additional possibilities.
• Protecting the vital interests of the data subject also justifies processing.

Sensitive data

Sensitive health data is subject to particularly strict protective measures. Processing is only permitted with special justifications and in compliance with GDPR requirements.

• Processing health data is lawful only if the requirements of Art. 9(2)(h) GDPR and at least one of the lawfulness conditions in Art. 6(1) are met.

In practice, knowledge and observance of the special categories are crucial. You recognize that authorities are increasingly punitive and the scope of protection is being expanded. The GDPR for health data requires a high degree of care and responsibility. This lays the foundation for a trustworthy and innovation-friendly health-data ecosystem.

Implementation

Flexible approaches

You are tasked with developing a Real-World Evidence pipeline that meets the requirements of the GDPR for health data. The variety of data sources and the heterogeneity of research data demand flexible solutions. You can use modular data-protection concepts tailored to specific data types and research goals. A dynamic roles-and-permissions model helps you control access to sensitive information in a targeted way. You benefit from a clear separation between research data and identifiers to minimize risks and ensure compliance.

Tip: Rely on adaptive processes that can quickly adjust to new regulatory requirements and technological developments. This creates an innovation-friendly environment and promotes the sustainable use of health data.

Anonymization & pseudonymization

You protect data subjects’ privacy by using proven methods of anonymization and pseudonymization. Anonymization prevents data from being attributed to a specific person and offers the highest level of data protection. Pseudonymization makes attribution more difficult by replacing identifiers with pseudonyms. The GDPR for health data emphasizes the importance of pseudonymization as a protective measure. In research, pseudonymization is particularly relevant because it reduces risk when processing sensitive data without limiting scientific utility.

• Anonymization: you remove all personal characteristics so that tracing back to an individual is excluded.
• Pseudonymization: you replace identifiers with codes that can only be reassigned using additional information.
• Both methods enable statistical analyses and minimize the risk in case of data breaches.

Note that true anonymization is hardly achievable in practice. According to international studies, a few attributes such as postal code, gender, and date of birth are sufficient to identify a large share of individuals in anonymized datasets. Pseudonymization therefore remains a central building block for the secure and GDPR-compliant processing of health data.

Technical measures

You rely on modern technical measures to ensure the security and integrity of your health data. Role concepts with clear access rights ensure that only authorized persons gain access. Access controls such as RBAC or LDAP help protect data from unauthorized access. You log and audit all access to create transparency and traceability. Data loss prevention (DLP) systems help safeguard data integrity.

• You anonymize or pseudonymize health data before further processing.
• You implement processes for handling data-subject rights, such as access and erasure requests.
• You protect data from unauthorized disclosure to third parties.
• You conduct regular training on data protection and confidentiality.

Note: Technical measures form the backbone of your data-protection strategy. They allow you to combine innovation and security and reliably meet the requirements of the GDPR for health data.

Organizational measures

You establish organizational structures that sustainably secure the protection of health data. Strict access controls ensure that only authorized persons gain access. You encrypt sensitive data to protect it from unauthorized access. Regular security audits help you identify and remedy vulnerabilities early. You continuously train your staff in handling sensitive data and in the requirements of the GDPR for health data.

You carry out a data protection impact assessment to identify risks at an early stage and take appropriate measures. Documenting all processes and processing activities creates transparency and facilitates communication with supervisory authorities. With these organizational measures, you ensure that your Real-World Evidence pipeline is not only legally compliant but also trustworthy and future-proof.

Data access and ecosystem

Metadata search services

You want to use and compare health data efficiently. Metadata search services play a central role. They help you quickly find relevant datasets and assess their quality. By providing metadata, you lay the foundation for open data and promote the development of modern health strategies.

• Metadata search services improve the discoverability of and access to health data.
• They enable you to compare data from different sources.
• Providing metadata forms the basis for innovative analyses and the use of open data.

With a well-structured metadata catalog, you can search for information in a targeted manner and increase transparency in the health-data ecosystem.

Data access

Access to health data in Germany is subject to strict rules. You must observe numerous GDPR requirements to protect patients’ rights. The most important challenges for data access include:

1. You inform patients comprehensively about the collection and processing of their data.
2. You document consent to data use carefully and in a provable manner.
3. When transferring data to external service providers, you obtain explicit consent.
4. You protect patient data from unauthorized access through technical and organizational measures.

These requirements build trust in digital health solutions and strengthen the acceptance of new care models.

Health-data ecosystem

Germany’s health-data ecosystem is diverse and dynamic. You benefit from close collaboration among various actors and instruments working together on innovative solutions. The following table provides an overview of the most important actors and their roles:

You operate in an ecosystem that combines innovation and data protection. With a clear focus on transparency and security, you actively shape the future of healthcare.

Challenges & best practices

Data minimization

You face the task of reducing the amount of processed health data to the necessary minimum. Technical hurdles often arise from outdated IT systems that hinder effective data minimization. Organizational resistance occurs when established processes are not questioned. You must strike a balance between data protection and the data needed for your business processes.

1. Outdated IT systems hinder implementation.
2. Entrenched processes create resistance.
3. You balance data protection and business requirements.

Entrenched processes and a lack of awareness of the need for data minimization lead to resistance. Clear data governance is crucial to overcoming these challenges.

Purpose limitation

You ensure purpose limitation by aligning the processing of health data strictly with defined research objectives. In German research institutions, the processing of special categories of personal data for scientific or historical purposes is also permissible without consent when necessary and where the controller’s interests prevail. You may restrict data-subject rights where necessary for research or statistical purposes. You anonymize data as soon as possible unless legitimate interests dictate otherwise.

1. Processing for scientific purposes possible without consent.
2. Restriction of rights to achieve research objectives.
3. Anonymization occurs as soon as it is possible.

Data protection impact assessment

You conduct a data protection impact assessment (DPIA) to identify risks in processing health data at an early stage. A DPIA is necessary to identify and assess data-protection risks in healthcare. You carry it out before introducing processing operations that involve risk. You assess specific risks and define appropriate security measures. Risk assessment and proportionality checks ensure that processing remains appropriate. In hospitals, you observe additional statutory requirements.

• Identification and assessment of risks
• Conducted before introducing new procedures
• Definition of technical and organizational measures
• Consideration of additional requirements in hospitals

Best practices

You rely on proven methods to ensure GDPR-compliant processing of health data. You adhere to specific data-protection requirements and conduct regular DPIAs. You implement appropriate technical and organizational measures to ensure the security and integrity of the data.

• Compliance with all data-protection requirements
• Regular DPIAs and process reviews
• Use of modern technical and organizational safeguards

Tip: Continuously review your processes and adapt them to new regulatory requirements. This creates an innovation-friendly and trustworthy environment for processing health data.

You build a GDPR-compliant Real-World Evidence pipeline by establishing clear processes, flexible data-protection concepts, and trustworthy structures. You rely on anonymization, pseudonymization, and continuous review. The future of the health-data ecosystem in Germany is dynamic:

1. The Health Data Use Act improves the use of health data for research and strengthens data protection.
2. The European Health Data Space creates a Europe-wide network for the secure exchange of health data.

With these developments, you promote innovation, market intelligence, and sustainable growth in healthcare.

FAQ

What is the difference between anonymization and pseudonymization?

Anonymization permanently removes all personal characteristics. You can no longer identify the data subject. Pseudonymization replaces identifiers with codes. With additional information, you can restore the linkage. Both methods effectively protect sensitive health data.

When do you need a data protection impact assessment (DPIA)?

You conduct a DPIA when you process health data on a large scale or use new technologies. The DPIA helps you identify risks early and plan appropriate safeguards. This ensures compliance with the GDPR.

How do you ensure that only authorized persons have access to health data?

You implement clear role concepts and access controls. Only authorized persons gain access to sensitive data. You regularly review permissions and log all access. This protects the data and strengthens data-subject trust.

What role do metadata search services play in the health-data ecosystem?

Metadata search services help you quickly find relevant datasets and assess their quality. You foster innovation by creating transparency and easing access to health data. This supports data-driven research and strategic decisions.

How can you implement data minimization in your pipeline?

You regularly analyze which data you really need. You remove unnecessary information and limit processing to what is necessary. Modern IT systems and clear processes help you implement data minimization efficiently and sustainably.

Making Sense of Markets with Clarity and Rigor

Markets rarely move in straight lines, and making sense of them depends less on chasing signals and more on assembling a clear picture from data, context, and disciplined interpretation. Objective equity research starts with careful gathering of information, but its value lies in how that information is framed—acknowledging uncertainty, highlighting what is measurable, and being transparent about assumptions. Methodological rigor ensures that analysis is not swayed by noise or narrative but grounded in observable dynamics. At VASRO, this ethos translates into a measured voice that values curiosity, precision, and clarity, helping to illuminate how complex market structures actually function rather than how they are imagined. This article is for general information only and does not constitute financial, investment, legal, or tax advice; readers should consult a licensed professional for advice tailored to their situation.

Disclaimer: The information on www.vasro.de is for general informational purposes only and does not constitute investment advice or a recommendation. VASRO GmbH does not provide personalized investment advice; visitors should seek independent financial guidance before making decisions. Some content may rely on third-party sources considered reliable, but VASRO GmbH does not guarantee accuracy, completeness, or timeliness. All information is provided “as is,” may change without notice, and VASRO GmbH has no obligation to update, correct, or continue publishing it. VASRO GmbH accepts no liability for losses arising from reliance on this information. Past performance is not a reliable indicator of future results.